Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Three skull models were found most useful for testing hydrocephalus valve programming.

New guidelines using video aim to ensure honest reporting of hair loss treatments.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Women with PCOS have a higher risk of heart disease.

Social media content on platelet-rich plasma is often poor quality and needs better regulation and more input from doctors.

Anticoagulant therapy may cause hair loss, especially in women, and stopping the medication can lead to hair regrowth.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

A manufacturing error in a dietary supplement caused severe selenium poisoning, affecting many people and highlighting the need for stricter quality control.

The guidelines suggest reconsidering PCOS criteria for better diagnosis and care.

Women are more likely to have long-term post-COVID symptoms than men.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Robotic surgery in plastic and reconstructive procedures improves precision and outcomes but faces challenges like high costs and long operating times.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Severe hair loss in women increases the risk of mental health issues, especially social anxiety.

Pharmacist-led care significantly improved post-COVID symptoms.

Nanotechnology can improve food safety, nutrition, and health, but safety and regulation challenges need addressing.